PH23102A - Therapeutic use of tin mesoporphyrin - Google Patents

Therapeutic use of tin mesoporphyrin

Info

Publication number
PH23102A
PH23102A PH33560A PH33560A PH23102A PH 23102 A PH23102 A PH 23102A PH 33560 A PH33560 A PH 33560A PH 33560 A PH33560 A PH 33560A PH 23102 A PH23102 A PH 23102A
Authority
PH
Philippines
Prior art keywords
mammals
heme
mesoporphyrin
therapeutic use
tin mesoporphyrin
Prior art date
Application number
PH33560A
Other languages
English (en)
Inventor
Attallah Kappas
George S Drummond
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of PH23102A publication Critical patent/PH23102A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Epoxy Resins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH33560A 1985-03-25 1986-03-20 Therapeutic use of tin mesoporphyrin PH23102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/715,515 US4657902A (en) 1985-03-25 1985-03-25 Therapeutic use of tin mesoporphyrin

Publications (1)

Publication Number Publication Date
PH23102A true PH23102A (en) 1989-04-10

Family

ID=24874343

Family Applications (2)

Application Number Title Priority Date Filing Date
PH33560A PH23102A (en) 1985-03-25 1986-03-20 Therapeutic use of tin mesoporphyrin
PH36831A PH24689A (en) 1985-03-25 1988-04-22 Therapeutic use of tin mesoporphyrin

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH36831A PH24689A (en) 1985-03-25 1988-04-22 Therapeutic use of tin mesoporphyrin

Country Status (15)

Country Link
US (1) US4657902A (da)
EP (1) EP0196079B1 (da)
JP (1) JPS62500787A (da)
KR (1) KR870700341A (da)
AT (1) ATE61221T1 (da)
AU (1) AU567041B2 (da)
CA (1) CA1293504C (da)
DE (1) DE3677804D1 (da)
DK (1) DK162716C (da)
ES (1) ES8800670A1 (da)
GR (1) GR860768B (da)
IE (1) IE58532B1 (da)
PH (2) PH23102A (da)
WO (1) WO1986005685A1 (da)
ZA (1) ZA861793B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
KR910009202B1 (ko) * 1985-10-23 1991-11-04 니혼메디피직스 가부시끼가이샤 포르피린 유도체의 제조방법
EP0249966A1 (en) * 1986-06-20 1987-12-23 The Rockefeller University Tin diiododeuteroporphyrin, its preparation and use, and pharmaceutical compositions thereof
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US4831024A (en) * 1987-10-15 1989-05-16 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice
US4997828A (en) * 1989-02-14 1991-03-05 The Rockefeller University Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
EP0450041B1 (en) * 1989-09-25 1993-11-03 The Rockefeller University Orally administered porphyrins to control intestinal iron absorption
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
US5149697A (en) * 1991-04-18 1992-09-22 Glaxo Inc. Cobalt porphyrin pharmaceutical compositions
FR2676738B1 (fr) * 1991-05-22 1995-05-05 Ir2M Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante.
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
AU7103594A (en) * 1993-06-14 1995-01-03 Rockefeller University, The Treatment of neonatal hyperbilirubin with metalloporphyrin
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
FI100454B (fi) * 1995-01-30 1997-12-15 Leiras Oy Hemi-tuotteiden uusi lääkinnällinen käyttö
AU6497996A (en) * 1995-08-02 1997-02-26 Warner-Lambert Company Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
CN1093541C (zh) * 1998-01-19 2002-10-30 徐濂 金属卟啉及其生产工艺
ES2163951B1 (es) 1998-07-29 2003-05-16 Airbus Espana Sl Un sistema de proteccion contra descargas electricas, especialmente rayos, de componentes estructurales de aviones.
ES2162718A1 (es) 1998-07-29 2002-01-01 Const Aeronauticas Sa Un sistema de proteccion contra descargas electricas, especialmente rayos, de componentes estructurales de aviones.
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
ATE312103T1 (de) 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
DE60233317D1 (de) * 2001-01-19 2009-09-24 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1439842A4 (en) * 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
NZ534912A (en) * 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
EP1509527B1 (en) 2002-06-04 2014-05-07 InfaCare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US7485721B2 (en) * 2002-06-07 2009-02-03 Duke University Substituted porphyrins
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US7008937B2 (en) * 2003-06-10 2006-03-07 Frontier Scientific, Inc. Porphyrins and metalloporphyrins for inhibiting heme iron uptake
AU2006232330A1 (en) * 2005-04-01 2006-10-12 Infacare Pharmaceutical Corporation Stannsoporfin compositions and administration
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
KR20140023447A (ko) 2006-10-04 2014-02-26 인파케어 파마슈티칼 코포레이션 스탄소포르핀의 고순도 대규모 제조법
CN102105146A (zh) 2008-05-23 2011-06-22 国立犹太保健医院 用于治疗与暴露于烷化物质有关的损伤的方法
ES2609110T3 (es) 2011-03-30 2017-04-18 Infacare Pharmaceutical Corporation Procedimientos de síntesis de mesoporfirinas metálicas
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
GB201120860D0 (en) 2011-12-05 2012-01-18 Cambridge Entpr Ltd Cancer immunotherapy
EP3200582B1 (en) 2014-09-29 2023-11-15 Fred Hutchinson Cancer Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
WO2017007955A1 (en) 2015-07-07 2017-01-12 The Research Foundation For The State University Of New York Use of amine carboxyboranes as therapeutic delivery of carbon monoxide and as general drug delivery system in the presence of reactive oxygen species
CN111603472A (zh) * 2020-06-09 2020-09-01 上海市闵行区中心医院 一种锡-中卟啉与青蒿素联合应用在制备抗肿瘤药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579533A (en) * 1968-03-18 1971-05-18 Antioch College Preparation of porphin,substituted porphin and metal chelates thereof
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
AU555679B2 (en) * 1981-07-15 1986-10-02 Rockefeller University, The Method of decreasing the rate of heme metabolism and composition used therefor
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin

Also Published As

Publication number Publication date
DK162716C (da) 1992-05-11
EP0196079A1 (en) 1986-10-01
ES8800670A1 (es) 1987-11-16
AU567041B2 (en) 1987-11-05
DK565786D0 (da) 1986-11-25
WO1986005685A1 (en) 1986-10-09
ES553306A0 (es) 1987-11-16
DK565786A (da) 1986-11-25
JPS62500787A (ja) 1987-04-02
EP0196079B1 (en) 1991-03-06
AU5549586A (en) 1986-10-23
DE3677804D1 (de) 1991-04-11
KR870700341A (ko) 1987-12-28
GR860768B (en) 1986-07-22
US4657902A (en) 1987-04-14
PH24689A (en) 1990-09-07
IE58532B1 (en) 1993-10-06
DK162716B (da) 1991-12-02
IE860751L (en) 1986-09-25
JPH0317806B2 (da) 1991-03-11
ATE61221T1 (de) 1991-03-15
ZA861793B (en) 1986-10-29
CA1293504C (en) 1991-12-24

Similar Documents

Publication Publication Date Title
GR860768B (en) Therapeutic use of tin mesoporphyrin
MY100682A (en) Novel biocidal mixture.
SG95092G (en) Use of substituted phenols as stabilizers
GR3005608T3 (da)
AU6562886A (en) Improvements in/or relating to the stunning of animals
EP0151989A3 (en) Means for the treatment of cardiac diseases
DE3687007D1 (en) 6-thioxanthinderivate.
PH22293A (en) Thienopyridone compounds and compositions with therapeutic activity
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
EP0364559A4 (en) Substituted adenine derivatives useful as therapeutic agents
EP0212501A3 (en) Therapeutic agent for treating hematopoietic diseases
AU1553388A (en) Treatment of diabetes
ES8502998A1 (es) Procedimiento para la preparacion de nuevas b-carbolinas substituidas.
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
JPS57159715A (en) Synergism of analgesic
EP0288488A4 (en) Dopamine- -hydroxylase inhibitors
JPS56166115A (en) Carcinostatic agent
DE3778165D1 (da)
NZ220242A (en) Regulating fertility in cattle by administering epostane
GB8829478D0 (en) Formulations
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
ES8301230A1 (es) Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles.
IL77975A (en) Topical therapeutic composition containing oxidation inhibitor system
GB8507539D0 (en) Administering liquid to animals